CEO Gause Named To Head Bayer Korea, Bayer Group Korea
This article was originally published in PharmAsia News
Bayer Korea has replaced its CEO, filling in for a retiring CEO who had worked for the Bayer Group subsidiary for 39 years. The new head of Bayer Korea and also head of Bayer Group Korea, is Friedrich-Wilhelm Gause, who had been chief of Bayer HealthCare Korea. Gause is expected to use his experience in the local and global markets in his leadership of the two subsidiaries. (Click here for more
You may also be interested in...
This month’s column covers deals announced between 1-23 April 2020.
Celltrion’s Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the WHO.
EU MDR Panel Discussion: Why An Extra Year Is Not Really A Delay For The MDR – How To Survive Changing And Confusing Times
26 May 2020, the date that the Medical Device Regulation was originally due to apply in the EU, was a good time to take stock of where the medtech sector finds itself. Three of the most renowned and outspoken experts on the EU medical device regulatory system gave their views in this exclusive interview.